Antibacterial Agents TRIZ Cases

Oral aminoglycoside cochleates reduce systemic toxicity while achieving 98% bacterial load reduction in refractory mycobacterial infections.

Bisnaphthalimidopropyl derivatives treat leishmaniasis by improving bioavailability while reducing dose-restricting toxicity.

Nifuratel sulfoxide overcomes metronidazole resistance in Atopobium vaginae by preventing persistent biofilm formation.

Cinnamomum extract activates Tie-2 phosphorylation to restore vascular stability and reduce wrinkles caused by ultraviolet radiation.

Novel substituted quinoline derivatives inhibit bacterial growth through dual pharmacophore mechanisms.

Cyclodextrin inclusion complexes stabilize unstable sulforaphane, resolving racemic mixture synthesis issues and improving bioavailability.

Using degradable linkers in polyionene synthesis to deliver potent antimicrobial activity while ensuring environmental degradability and low toxicity.

Carrier protein with site-directed mutation incorporates unnatural amino acids to enable specific click chemistry conjugation.

Repeating lysine-tryptophan peptides bypass antibiotic resistance by physically disrupting bacterial inner membranes, offering a safe preservative solution.

Modifying diphenyl sulfide structures yields selective S1P3 antagonists that treat sepsis without causing hemorrhaging or increasing vascular permeability.

Bridged bicyclic heteroaryl substituted triazoles target the Axl receptor tyrosine kinase to modulate cellular signaling pathways.

Orthogonal protecting groups resolve synthesis complexity while enabling access to unnatural analogs for treating proliferative diseases.

Octameric VHH binding agents derived from camelid immunoglobulins neutralize Clostridium difficile toxins A and B.

Therapeutic agents inhibit M protein and MYO5B interaction, preventing viral assembly without complex host modifications.

Engineered lactic acid bacteria express chimeric SlpA to block Clostridium difficile binding, avoiding antibiotic resistance.

Bacillus subtilis spores display vaccine antigens to maintain protective immunity at room temperature.

Imidazole-piperidinyl derivatives modulate kinase activity by inhibiting p70S6K and Akt, addressing inadequate control of hyperactive protein kinases.

Reduces inactivated poliovirus dose while maintaining protection efficacy through optimized adjuvant adsorption and preservative systems.

Nitric oxide eluting polymers release controlled doses to treat skin disorders without causing irritation or resistance.

Ethyl oleate reduces the viscosity of a non-aqueous high concentration antibody suspension, enabling effective manual injection.

Piperidinyl substituted naphthyridinones target bacterial fatty acid biosynthesis by incorporating cyclic amino groups directly attached to carbonyl moieties.

Heated eyewear softens clogged meibomian glands while doxycycline tablets inhibit bacterial growth, preventing recurring infections and stabilizing the tear film.

Co-stimulation with CD3 and CD28 antibodies enables adenoviral vectors to achieve stable transgene expression without insertional mutagenesis risks.

GLP-1 mimetibody constructs deliver sustained metabolic benefits through engineered protein stability.

Calcium phosphate precipitates ionically bound to lipid bilayers release bioactive compounds into cells, reducing toxicity and immunogenic responses.

Segmented chaperonin 60.1 peptides deliver prolonged pain relief while reducing side effects associated with conventional medications.

Sphingosine analogs restore airway antibacterial defense mechanisms to treat Pseudomonas aeruginosa infections in cystic fibrosis and COPD patients.

Preliminary iron chelation disrupts biofilms to enhance non-iron porphyrin efficacy against resistant bacteria.

A humanized anti-human RAGE monoclonal antibody retains binding affinity through framework region modification.

siRNA-hydrophilic polymer conjugates improve stability and cellular uptake, resolving low permeability and degradation issues in gene therapy.